Confirmatory Clinical Trial for Verifying the Efficacy and Safety of 'ALZGUARD' as a Digital Dementia Diagnostic Aid-Tool for the Diagnosis of the Major Neurocognitive Disorders

NARecruitingINTERVENTIONAL

Enrollment

122

Participants

Timeline

Start Date

September 12, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions

DementiaMajor Neurocognitive Disorder

Interventions

DEVICE

ALZGUARD

A digital therapeutic(DTx) application that uses artifical intelligence to analyze cognitive function and provide a diagnosis of dementia.

Trial Locations (3)

RECRUITING

Kangwon National University Hospital, Chuncheon

RECRUITING

Ewha Womans University Mokdong Medical Center, Seoul

RECRUITING

Yongin Severance Hospital, Seoul

All Listed Sponsors

lead

HAII corp.ltd

INDUSTRY